Effect of fetal hemoglobin-stimulating medicines on the interaction of DNA and protein of important erythroid regulatory elements

Biochemistry and Cell Biology

Volumn 81, Issue 4, 2003, Pages 297-305

  Ji, Xin Jun ^a   Liu, De Pei ^a   Xu, Dong Dong ^a   Li, Lei ^a   Liang, Chih Chuan ^a  

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

Author keywords

globin; Hydroxyurea; In vivo footprinting; LCR; Ligation mediated PCR

Indexed keywords

CELLS; DNA; GENES; MEDICINE; SYNTHESIS (CHEMICAL);

GENE PROMOTORS;

BIOCHEMISTRY;

ALPHA GLOBIN; AZACITIDINE; BETA GLOBIN; BUSULFAN; BUTYRIC ACID; CYTARABINE; HEMOGLOBIN F; HYDROXYUREA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BETA THALASSEMIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DNA FOOTPRINTING; ERYTHROID CELL; HUMAN; HUMAN CELL; MALE; MOLECULAR PROBE; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PROTEIN DNA BINDING; PROTEIN SYNTHESIS; SICKLE CELL ANEMIA;

ANEMIA, SICKLE CELL; ANIMALS; ANTISICKLING AGENTS; BASE SEQUENCE; BETA-THALASSEMIA; BONE MARROW; DNA FOOTPRINTING; DNA-BINDING PROTEINS; ERYTHROID CELLS; FETAL HEMOGLOBIN; GLOBINS; MALE; MICE; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS (GENETICS);

ANIMALIA;

EID: 0344826786     PISSN: 08298211     EISSN: None     Source Type: Journal    
DOI: 10.1139/o03-058     Document Type: Article

References (53)

1. Alter, B.P., and Goff, S.C. 1980. A murine model for the switch from fetal to adult hemoglobin during ontogeny. Blood, 56: 1100-1105.
2. Anderson, W.F., Goldberg, S., Kantoff, P., Berg, P., Eglitis, M., and Humphries, R.K. 1985. Attempts at gene therapy in beta-thalassemic mice. Ann. N.Y. Acad. Sci. 445: 445-451.
3. Andrews, N.C., Erdjument-Bromage, H., Davidson, M.B., Tempst, P., and Orkin, S.H. 1993. Erythroid transcription factor NF-E2 is a haematopoietic- specific basic-leucine zipper protein. Nature (Lond.), 362: 722-728.
4. Asano, H., and Stamatoyannopoulos, G. 1998. Activation of beta-globin promoter by erythroid Kruppel-like factor. Mol. Cell. Biol. 18: 102-109.
5. Atweh, G.F., and Schechter, A.N. 2001. Pharmacologic induction of fetal hemoglobin: raising the therapeutic bar in sickle cell disease. Curr. Opin. Hematol. 8: 123-130.
6. Beuzard, Y. 1996. Towards gene therapy of hemoglobinopathies. Semin. Hematol. 33: 43-52.
7. Bieker, J.J., and Southwood, C.M. 1995. The erythroid Kruppel-like factor transactivation domain is a critical component for cell-specific inducibility of a β-globin promoter. Mol. Cell. Biol. 15: 852-860.
8. Bulger, M., and Groudine, M. 1999. Looping versus linking: toward a model for long-distance gene activation. Genes Dev. 13: 2465-2477.
9. Constantoulakis, P., Josephson, B., Mangahas, L., Papayannopoulou, T., Enver, T., Costantini, F., and Stamatoyannopoulos, G. 1991. Locus control region-A gamma transgenic mice: a new model for studying the induction of fetal hemoglobin in the adult. Blood, 77: 1326-1333.
10. Curcio, M.J., Kantoff, P., Schafer, M.P., Anderson, W.F., and Safer, B. 1986. Compensatory increase in levels of beta minor globin in murine beta-thalassemia is under translational control. J. Biol. Chem. 261: 16 126-16 132.
11. DeSimone, J., Heller, P., Hall, L., and Zwiers, D. 1982. 5-Azacytidine stimulates fetal hemoglobin synthesis in anemic baboons. Proc. Natl. Acad. Sci. U.S.A. 79: 4428-4431.
12. Evans, T., Felsenfeld, G., and Reitman, M. 1990. Control of globin gene transcription. Annu. Rev. Cell Biol. 6: 95-124.
13. Forrester, W.C., Thompson, C., Elder, J.T., and Groudine, M. 1986. A developmentally stable chromatin structure in the human β-globin gene cluster. Proc. Natl. Acad. Sci. U.S.A. 83: 1359-1363.
14. Frederick, M.A. 1995. Short protocol in molecular biology. John Wiley & Sons, Inc., New York.
15. Garrity, D.A., and Wold, B.J. 1992. Effects of different DNA polymerases in ligation-mediated PCR: enhanced genomic sequencing and in vivo footprinting. Proc. Natl. Acad. Sci. U.S.A. 89: 1021-1025.
16. Ginder, G.D., Whitters, M.J., and Pohlman, J.K. 1984. Activation of a chicken embryonic globin gene in adult erythroid cells by 5-azacytidine and sodium butyrate. Proc. Natl. Acad. Sci. U.S.A. 81: 3954-3958.
17. Grosveld, F., Assendelft, G.B., Greaves, D.R., and Kollias, G. 1987. Position-independent, high-level expression of the human beta-globin gene in transgenic mice. Cell, 51: 975-985.
18. Hardison, R., Slightom, J.L., Gumucio, D.L., Goodman, M., Stojanovic, N., and Miller, W. 1997. Locus control regions of mammalian β-globin gene clusters: combining phylogenetic analyses and experimental results to gain functional insights. Gene, 205: 73-94.
19. Ikuta, T., Kan, Y.W., Swerdlow, P.S., Faller, D.V., and Perrine, S.P. 1998. Alterations in protein-DNA interactions in the gamma-globin gene promoter in response to butyrate therapy. Blood, 92: 2924-2933.
20. Jackson, D.A., McDowell, J.C., and Dean, A. 2003. Beta-globin locus control region HS2 and HS3 interact structurally and functionally. Nucleic Acids Res. 31: 1180-1190.
21. Ji, X., Liu, D., Xu, D., Li, L., Wang, J., and Liang, C. 2000. Both locus control region and proximal regulatory elements direct the developmental regulation of beta-globin gene cluster. J. Cell. Biochem. 76: 376-385.
22. Kadonaga, J.T., Carner, K.R., Masiara, F.R., and Tjian, R. 1987. Isolation of cDNA encoding transcription factor Sp1 and functional analysis of the DNA binding domain. Cell, 51: 1079-1090.
23. Kataoka, K., Igarashi, K., Itoh, K., Fujiwara, K.T., Noda, M., Yamamoto, M., and Nishizawa, M. 1995. Small Maf proteins heterodimerize with Fos and may act as competitive repressors of the NF-E2 transcription factor. Mol. Cell. Biol. 15: 2180-2190.
24. Leroy-Viard, K., Rouyer-Fessard, P., and Beuzard, Y. 1991. Improvement of mouse beta-thalassemia by recombinant human erythropoietin. Blood, 78: 1596-1602.
25. Letvin, N.L., Linch, D.C., Beardsley, G.P., McIntyre, K.W., and Nathan, D.G. 1984. Augmentation of fetal-hemoglobin production in anemic monkeys by hydroxyurea. N. Engl. J. Med. 310: 869-873.
26. Ley, T.J., DeSimone, J., Anagnou, N.P., Keller, G.H., Humphries, R.K., Turner, P.H., Young, N.S., Keller, P., and Nienhuis, A.W. 1982. 5-Azacytidine selectively increases gamma-globin synthesis in a patient with beta+ thalassemia. N. Engl. J. Med. 307: 1469-1475.
27. Li, Q., Peterson, K.R., Fang, X., and Stamatoyannopoulos, G. 2002. Locus control regions. Blood, 100: 3077-3086.
28. Liang, C., Liu, D., Jia, P., Ao, Z., Chen, S., and Yang, K. 1987. In Developmental control of globin gene expression. Edited by G. Stamatoyannopoulos and A.W. Nienhuis. Alan R. Liss Inc., New York. pp. 467-478.
29. Liu, D., Liang, C., Ao, Z., Jia, P., Chen, S., Wang, R., Liu, L., Jin, H., Zha, D., and Huang, Y.W. 1990. Treatment of severe beta-thalassemia (patients) with myleran. Am. J. Hematol. 33: 50-55.
30. Molete, J.M., Petrykowska, H., Sigg, M., Miller, W., and Hardison, R. 2002. Functional and binding studies of HS3.2 of the beta-globin locus control region. Gene, 283: 185-97.
31. Nienhuis, A.W., Ley, T.J., Humphries, R.K., Young, N.S., and Dover, G. 1985. Pharmacological manipulation of fetal hemoglobin synthesis in patients with severe beta-thalassemia. Ann. N.Y. Acad. Sci. 445: 198-211.
32. Nienhuis, A.W., Hanawa, H., Sawai, N., Sorrentino, B.P., and Persons, D.A. 2003. Development of gene therapy for hemoglobin disorders. Ann. N.Y. Acad. Sci. 996: 101-111.
33. Olivieri, N.F. 1996. Reactivation of fetal hemoglobin in patients with beta-thalassemia. Semin. Hematol. 33: 24-42.
34. Oyake, T., Itoh, K., Motohashi, H., Hayashi, N., Hoshino, H., Nishizawa, M., Yamamoto, M., and Igarashi, K. 1996. Bach proteins belong to a novel family of BTB-basic leucine zipper transcription factors that interact with MafK and regulate transcription through the NF-E2 site. Mol. Cell. Biol. 16: 6083-6095.
35. Papayannopoulou, T., Torrealba, R.A., Veith, R., Knitter, G., and Stamatoyannopoulos, G. 1984. Arabinosylcytosine induces fetal hemoglobin in baboons by perturbing erythroid cell differentiation kinetics. Science (Washington, D.C.), 224: 617-619.
36. Perrine, S.P., Ginder, G.D., Faller, D.V., Dover, G.H., Ikuta, T., Witkowska, H.E., Cai, S.P., Vichinsky, E.P., and Olivieri, N.F. 1993. A short-term trial of butyrate to stimulate fetal-globin-gene expression in the beta-globin disorders. N. Engl. J. Med. 328: 81-86.
37. Reddy, P.M.S., and Shen, C.K.J. 1993. Erythroid differentiation of mouse erythroleukemia cells results in reorganization of protein-DNA complexes in the mouse beta maj globin promoter but not its distal enhancer. Mol. Cell. Biol. 13: 1093-1103.
38. Ronchi, A.E., Bottardi, S., Mazzucchelli, C., Ottolenghi, S., and Santoro, C. 1995. Differential binding of the NFE3 and CP1/NFY transcription factors to the human gamma-and epsilon-globin CCAAT boxes. J. Biol. Chem. 270: 21 934-21 941.
39. Sambrook, J., Fritsch, E.F., and Maniatis, T. 1989. Molecular cloning: a laboratory manual. 2nd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
40. Sauvage, C., Rouyer-Fessard, P., and Beuzard, Y. 1993. Improvement of mouse beta thalassaemia by hydroxyurea. Br. J. Haematol. 84: 492-496.
41. Stuve, L.L., and Myers, R.M. 1990. A directly repeated sequence in the beta-globin promoter regulates transcription in murine erythroleukemia cells. Mol. Cell. Biol. 10: 972-981.
42. Tang, Y., Liu, D., and Liang, C.C. 2002. Further understanding of the beta-globin locus regulation at the molecular level: looping or linking models? Genes Cells, 7: 889-900.
43. Tolhuis, B., Palstra, R.J., Splinter, E., Grosveld, F., and de Laat, W. 2002. Looping and interaction between hypersensitive sites in the active beta-globin locus. Mol. Cells 10: 1453-1465.
44. Trainor, C.D., Omichinski, J.G., Vandergon, T.L., Gronenborn, A.M., Clore, G.M., and Felsenfeld, G. 1996. A palindromic regulatory site within vertebrate GATA-1 promoters requires both zinc fingers of the GATA-1 DNA-binding domain for high-affinity interaction. Mol. Cell. Biol. 16: 2238-2247.
45. Tuan, D., Solomon, W., Li, Q., and London, I.M. 1985. The "beta-like-globin" gene domain in human erythroid cells. Proc. Natl. Acad. Sci. U.S.A. 82: 6384-6388.
46. Veith, R., Papayannopoulou, T., Kurachi, S., and Stamatoyannopoulos, G. 1985. Treatment of baboon with vinblastine: insights into the mechanisms of pharmacologic stimulation of HbF in the adult. Blood, 66: 456-459.
47. Whitney, J.B. 3rd. 1977. Differential control of the synthesis of two hemoglobin beta chains in normal mice. Cell, 12: 863-871.
48. Wijgerde, M., Grosveld, F., and Fraser, P. 1995. Transcription complex stability and chromatin dynamics in vivo. Nature (Lond.), 377: 209-213.
49. Wood, W.G. 1996. The complexities of beta globin gene regulation. Trends Genet. 12: 204-206.
50. Xiao, J.H., Davidson, I., Macchi, M., Rosales, R., Vigneron, M., Staub, A., and Chambon, P. 1987. In vitro binding of several cell-specific and ubiquitous nuclear proteins to the GT-I motif of the SV40 enhancer. Genes Dev. 1: 794-807.
51. Xu, D., Liu, D., Ji, X., Lv, X., and Liang, C.C. 2001. In vivo DNA-protein interactions at hypersensitive site 3.5 of the human beta-globin locus control region. Biochem. Cell Biol. 79: 747-754.
52. Yang, Y.M., and Pace, B. 2001. Pharmacologic induction of fetal hemoglobin synthesis: cellular and molecular mechanisms. Pediatr. Pathol. Mol. Med. 20: 87-106.
53. Yang, J., Kawai, Y., Hanson, R.W., and Arinze, I.J. 2001. Sodium butyrate induces transcription from the G alpha(i2) gene promoter through multiple Sp1 sites in the promoter and by activating the MEK-ERK signal transduction pathway. J. Biol. Chem. 276: 25 742-25 752.